BRIEF-EMA Recommends Moderna's COVID-19 Vaccine For Authorisation In EU

BRIEF-EMA Recommends Moderna's COVID-19 Vaccine For Authorisation In EU
Representative Image

European Medicines Agency: * EMA RECOMMENDS COVID-19 VACCINE MODERNA FOR AUTHORISATION IN EU

* EMA SAYS COVID-19 VACCINE MODERNA IS GIVEN AS TWO INJECTIONS INTO ARM, 28 DAYS APART * EMA SAYS RECOMMENDED GRANTING CONDITIONAL MARKETING AUTHORISATION FOR COVID-19 VACCINE MODERNA IN PEOPLE FROM 18 YEARS OF AGE.

* EMA SAYS THE EUROPEAN COMMISSION WILL NOW FAST-TRACK DECISION-MAKING PROCESS TO GRANT A DECISION ON THE CONDITIONAL MARKETING AUTHORISATION FOR COVID-19 VACCINE MODERNA * EMA SAYS COMPANY THAT MARKETS COVID-19 VACCINE MODERNA WILL CONTINUE TO PROVIDE RESULTS FROM THE MAIN TRIAL, WHICH IS ONGOING, FOR 2 YEARS Source text: (https://bit.ly/2XgIpIg) Further company coverage:

Also Read: European Medicines Agency meeting early to discuss Moderna coronavirus vaccine

Give Feedback

Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.

By submitting, you agree that we may use your email address to respond.